**Core Concept**
The management of Cervical Intraepithelial Neoplasia (CIN) II involves understanding the risk of progression to invasive cervical cancer. CIN II is a precancerous lesion characterized by the presence of mild to moderate dysplasia, with a risk of malignant transformation that is intermediate between CIN I and CIN III.

**Why the Correct Answer is Right**
The risk of malignancy in CIN II is estimated to be around 1-5% per year, which is significantly lower than CIN III but higher than CIN I. This increased risk is due to the presence of more severe dysplastic changes, including the presence of high-grade squamous intraepithelial lesions (HSIL) in some cases. The risk of malignancy in CIN II can be assessed using the Reid index, which measures the depth of invasion of the lesion into the epithelium. A Reid index of 6 or greater is associated with a higher risk of malignancy.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because CIN I has a very low risk of malignancy, typically less than 1% per year.
**Option B:** This option is incorrect because CIN III has a significantly higher risk of malignancy, often exceeding 10-20% per year.
**Option C:** This option is incorrect because the risk of malignancy in CIN II is not as high as 50%, which is more characteristic of invasive cervical cancer.

**Clinical Pearl / High-Yield Fact**
The management of CIN II often involves a conservative approach, with regular follow-up and colposcopy to monitor for progression to more severe lesions. In some cases, treatment with ablative or excisional techniques may be necessary to prevent the development of invasive cancer.

**Correct Answer: D.**